BICHEN PHARMACEUTICAL

bichen-pharmaceutical-logo

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

#SimilarOrganizations #Financial #Website #More

BICHEN PHARMACEUTICAL

Social Links:

Industry:
Biopharma Health Care Medical Pharmaceutical

Founded:
2015-01-01

Address:
Shanghai, Shanghai, China

Country:
China

Website Url:
http://www.abmtx.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
50 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Amazon Apache Microsoft Exchange Online Office 365 Mail GoDaddy DNS Japanese Yen


Similar Organizations

allorion-therapeutics-logo

Allorion Therapeutics

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

jisi-yingda-logo

Jisi Yingda

Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.

marius-pharmaceuticals-logo

Marius Pharmaceuticals

Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

oncohost-logo

OncoHost

OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.

sunshine-biopharma-logo

Sunshine Biopharma

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

tarsier-pharma-logo

Tarsier Pharma

Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.

Investors List

delta-capital-2_image

Delta Capital

Delta Capital investment in Series B - Bichen Pharmaceutical

sincere-capital_image

Sincere Capital

Sincere Capital investment in Series B - Bichen Pharmaceutical

viva-biotech_image

Viva BioInnovator

Viva BioInnovator investment in Series B - Bichen Pharmaceutical

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Series B - Bichen Pharmaceutical

photon-fund_image

Photon Fund

Photon Fund investment in Series B - Bichen Pharmaceutical

baidu-ventures_image

Baidu Ventures

Baidu Ventures investment in Series B - Bichen Pharmaceutical

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series B - Bichen Pharmaceutical

tongde-capital_image

Tongde Capital

Tongde Capital investment in Series B - Bichen Pharmaceutical

honghui-capital_image

Honghui Capital

Honghui Capital investment in Series B - Bichen Pharmaceutical

sinopharm-capital_image

Sinopharm Capital

Sinopharm Capital investment in Series A - Bichen Pharmaceutical

Official Site Inspections

http://www.abmtx.com

  • Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
  • IP address: 3.33.152.147
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Bichen Pharmaceutical"

ABM-About Us - abmtx.com

Contact Us Email: [email protected] Company Overview ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as …See details»

Abmtx 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Abmtx. Use the PitchBook Platform to explore the full profile.See details»

ABMTX - Products, Competitors, Financials, Employees, …

About ABMTX ABM Therapeutics is a drug discovery company focused on small molecule targeted therapies within the biopharmaceutical industry. The company develops treatments …See details»

ABM Therapeutics - Company Profile & Staff Directory | ContactOut

ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»

ABM Therapeutics - Viva BioInnovator

ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»

CRC Oncology – Caring | Sharing | Supporting

Dec 10, 2019 For more information, please contact [email protected]. About CRC Oncology CRC Oncology is a contract research organization (CRO) focused on reshaping the global …See details»

Bichen Pharmaceutical - Crunchbase Company Profile & Funding

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.See details»

abmtx.com - ABM-Home

Apr 12, 2024 ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast …See details»

ABM Therapeutics Overview | SignalHire Company Profile

ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»

ABM Therapeutics Receives IND Approval in China for …

Nov 30, 2021 ABM-1310 is a brain-penetrant BRAF inhibitor. Due to its high selectivity and optimal physicochemical properties, as well as superior efficacies and high margin of safety in preclinical models, it ...See details»

ABM Therapeutics Company Overview, Contact Details

Jan 4, 2022 Learn more about ABM Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

ABM-Investors - abmtx.com

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management …See details»

ABM-R&D Strategy - abmtx.com

ABM-1310 is highly potent and selective BRAF inhibitor with an excellent cell permeability and brain penetration. The compound was designed to address majority of BRAF V600E mutated …See details»

ABM-About Us - abmtx.com

Contact Us Email: [email protected] Management Team Chen Chen, Ph.D. Chairman & CEO, Founder Dr. Chen is founder and CEO of ABM. Before ABM was established, Dr. Chen was …See details»

ABM-News - abmtx.com

Founded in 1907, the American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the conquest of cancer. It has over …See details»

ABM-About Us - abmtx.com

Contact Us Email: [email protected] Mission We are committed for scientific excellence and innovation. We are passionate about taking challenges and tirelessly pursuing best medical …See details»

American Beacon Mid-Cap Value F (ABMTX) - Yahoo Finance

See the company profile for American Beacon Mid-Cap Value F (ABMTX) including business summary, industry/sector information, number of employees, business summary, corporate …See details»

璧辰医药-ABM Therapeutics, Inc-企业详情-InvestGO数据库 …

Dec 31, 2014 查看医药魔方InvestGO®数据库璧辰医药的公司信息。璧辰医药(ABM Therapeutics, Inc),公司简介:ABM is an innovative drug discovery and development …See details»

ABM Therapeutics Announces First Patient Dosed in Phase 1 …

SAN DIEGO, June 22, 2020 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced …See details»

American Beacon Mid-Cap Value F (ABMTX) - Yahoo Finance Canada

Apr 30, 2025 Find the latest American Beacon Mid-Cap Value F (ABMTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

linkstock.net © 2022. All rights reserved